Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Query: "AREA[SponsorSearch](Sunshine Guojian Pharmaceutical)"
Count: 16
Selected: 0
NCT IDTitle
NCT04445038Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-5 Humanized Monoclonal Antibody Injection
NCT05027373Safety, Tolerability and Pharmacokinetic of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection
NCT04922151601 Versus Ranibizumab in Patients With Pathological Myopic Choroidal Neovascularization (pmCNV)
NCT04667910601 Versus Ranibizumab in Patients With Central Retinal Vein Occlusion (CRVO)
NCT04667897601 Versus Ranibizumab in Patients With Branch Retinal Vein Occlusion (BRVO)
NCT04527718Study of the Safety, Tolerability and Pharmacokinetics of 611 in Adult Healthy Volunteers
NCT04468997The Study of Drug 601 in Patients With Wet Age-related Macular Degeneration (wAMD)
NCT04466254Efficacy and Safety Study of Combination of CPGJ602 and Chemotherapy, in First Line, With Wild KRAS/NRAS/BRAF in Metastatic Colorectal Cancer
NCT04367441Randomized, Double Blinded, Placebo Controlled, Single Dose Escalation Study of 608 in Healthy Subjects
NCT04345458Safety and Efficacy Study of Prefilled Liquid Etanercept(Yisaipu) for Active Ankylosing Spondylitis
NCT04151407The Study of Drug 601 in Patients With Diabetic Macular Edema (DME)
NCT03998345Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A in China
NCT03980379Pharmacokinetics, Efficacy and Safety of the 304 Injection
NCT03950297Phase 1, First in Human, Open-Label, Dose-Escalation Study of 609A
NCT03356158A Study of Recombinant Anti-EGFR Monoclonal Antibody in Patients With Metastatic Colorectal Cancer
NCT04079374Comparative Efficacy, Safety and Immunogenicity Study of Etanercept and Enbrel